ACA
PRDS
Arena Capital Advisors’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-826,104
| Closed | -$1.5M | – | 60 |
|
|
2023
Q2 | $1.5M | Sell |
826,104
-25,177
| -3% | -$45.6K | 5% | 5 |
|
|
2023
Q1 | $1.12M | Hold |
851,281
| – | – | 1.57% | 15 |
|
|
2022
Q4 | $1.44M | Hold |
851,281
| – | – | 0.79% | 37 |
|
|
2022
Q3 | $1.58M | Hold |
851,281
| – | – | 0.48% | 61 |
|
|
2022
Q2 | $2.61M | Hold |
851,281
| – | – | 0.66% | 55 |
|
|
2022
Q1 | $6.15M | Sell |
851,281
-336,168
| -28% | -$2.43M | 0.93% | 35 |
|
|
2021
Q4 | $19.4M | Sell |
1,187,449
-858,149
| -42% | -$14M | 1.79% | 7 |
|
|
2021
Q3 | $20.4M | Buy |
2,045,598
+532,393
| +35% | +$5.3M | 1.61% | 7 |
|
|
2021
Q2 | $15.1M | Buy |
1,513,205
+1,182,588
| +358% | +$11.8M | 1.25% | 9 |
|
|
2021
Q1 | $3.29M | Buy |
+330,617
| New | +$3.29M | 0.33% | 101 |
|